The PTP1B Tyrosine Phosphatase Drug Discovery Kit is a colorimetric, non-radioactive assay designed to measure the phosphatase activity of purified PTP1B. This 96-well assay is useful for screening inhibitors and modulators of PTP1B activity.The kit includes human, recombinant PTP1B (residues 1-322; MW=37.4 kDa), expressed in E. coli. The detection of free phosphate released is based on the classic Malachite green assay and offers the advantages of convenient, 1-step detection and excellent sensitivity, without radioactivity. PTP1B (protein tyrosine phosphatase-1B) is a ubiquitous, nontransmembrane protein tyrosine phosphatase, originally identified in human placenta.
It is implicated in the negative regulation of insulin receptor signaling, and is a potential therapeutic target for treatment of type 2 diabetes and obesity. The phosphopeptide substrate supplied with this kit (“IR5”, Prod. No. BML-P315, pTyr
1158 (a.k.a. pTyr
1146, mature peptide numbering)) contains sequence from the insulin receptor ß subunit domain that must be autophosphorylated to achieve full receptor kinase activation. This “activation loop” is the target of several protein phosphatase regulators of insulin signaling, including, notably, PTP1B. The PTP1B inhibitor suramin (Prod. No. BML-KI469) is supplied as a control for inhibitor detection. Suramin is a reversible and competitive inhibitor of PTP1B, with a K
i of 5.5 µM.
Product Specification
| Quantity: | 96 assays |
| |
| Kit/Set Contains: | PTP 1B Enzyme (human recombinant) (Prod. No. BML-SE332-9092)(5 µg; 0.1 µg/µl in 50 mM HEPES, pH 7.2, 1 mM EDTA, 1 mM DTT, 0.05% NP-40, 10% (v/v) glycerol)Storage: -70°C. Avoid freeze/thaw cycles Substrate (“IR5” Insulin Receptor ß, residues 1142-1153, pY1146) (Prod. No. BML-P315-9090)(1 mg; Lyophilized solid)Storage: -20 or -70°C. 2X Assay Buffer (Prod. No. BML-KI467)(20 ml; 100 mM MES, pH 6.0, 300 mM NaCl, 2 mM EDTA, 2 mM DTT, 0.1% NP-40 Storage: -70°C Biomol Red™ Concentrated Phosphate Detection Reagent (Prod. No. BML-KI468)(5 ml; Liquid in screw-cap plastic bottle)Storage: 4°C. Long-term at -70°C. Suramin (PTP1B inhibitor) (Prod. No. BML-KI469)(10 mg; Solid)Storage: -70°C Phosphate Standard (Prod. No. BML-KI470)(0.5 ml; 100 µM in 1X Assay Buffer)Storage: -20 or -70°C ½-VOLUME MICROPLATE (Prod. No. BML-KI101)Storage: RT |
| |
| Long Term Storage: | -80°C |
| |
| Use/Stability: | Store all components except the microtiter plate at -70°C for the highest stability. The PTP1B enzyme component BML-SE332-9092 must be handled particularly carefully in order to retain maximal enzymatic activity. Thaw it quickly in a RT water bath or by rubbing between fingers, then immediately store on an ice bath. The remaining unused enzyme should be ‘snap’ frozen, e.g. in liquid nitrogen or a dryice/ethanol bath, and stored at -70°C. If only a few assays are to be performed each day, the PTP1B may be divided into several aliquots (best if ≥10 µl)) to help minimize freeze/thaw cycles. |
| |
| Background / Technical Information: | Please click here for the comprehensive product datasheet. |
| |
General Literature References
Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance: B. Xue et al.; J. Biol. Chem.
282, 23829 (2007),
Abstract;
SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B: C. Sun et al.; Cell. Metab.
6, 307 (2007),
Abstract;
Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases: D.F. McCain et al.; J. Biol. Chem
279, 14713 (2004),
Abstract;
Mechanism of transmembrane signaling: insulin binding and the insulin receptor: F.P. Ottensmeyer et al.; Biochemistry
39, 12103 (2000),
Abstract;
Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B: A. Salmeen et al.; Mol. Cell.
6, 1401 (2000),
Abstract;
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene: M. Elchbly et al.; Science
283, 1544 (1999),
Abstract;
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog: S.R. Hubbard; Embo. J.
16, 5572 (1997),
Abstract;
Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design: Y.A. Pius et al.; PNAS
94, 13420 (1997),
Abstract;
Direct binding of the proline-rich region of protein tyrosine phosphatase 1B to the Src homology 3 domain of p130(Cas): F. Liu et al.; J. Biol. Chem.
271, 31290 (1996),
Abstract;
Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides: K.W. Harder et al.; Biochem. J.
298, 395 (1994),
Abstract;
Sequential dephosphorylation of a multiply phosphorylated insulin receptor peptide by protein tyrosine phosphatases: C. Ramachandran et al.; Biochemistry
31, 4232 (1992),
Abstract;
Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin: B. Martin et al.; J. Biol. Chem.
260, 14932 (1985),
Abstract;